24 days ago • Posted by William Ramstein

FDA cracks down on drug applications--smaller biotech firms see shares fall

Regulatory setbacks for drug applications from Acadia, Athenex and FibroGen have seen their share prices fall late last night. The nasdaq biotech index slumped 1.6% a deeper drop than the broader market and the SPDR biotech ETF (XBI) fell 2.4%.

Source: Bloomberg

bg_nwsletter